Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

被引：1
|
作者：
Khan, Sana Irfan
Anwar, Muhammad Yasir
Rafae, Abdul
Khan, Anam
Khan, Atif Irfan
Aamir, Sobia
Batool, Syeda Sabeeka
Din, Asim Tameez Ud
Khan, Israr
Javaid, Anum
Qadeer, Haifza Abeera
Ahmed, Zahoor
Gul, Rohail
Aijaz, Zobia
Anwer, Faiz
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134986
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Revival of PI3K inhibitors in non-Hodgkin's lymphoma
    Batlevi, C. L.
    Younes, A.
    ANNALS OF ONCOLOGY, 2017, 28 (09) : 2047 - 2049
  • [2] An updated systematic review and meta-analysis of the safety and efficacy of phosphoinositide 3-kinase inhibitors (PI3Ki) in advanced breast cancer
    Raphael, Jacques
    Hussaini, Syed
    Pritchard, Kathleen I.
    Shah, Prakesh
    Blanchette, Phillip
    Fernandes, Ricardo
    Desautels, Danielle
    CANCER RESEARCH, 2020, 80 (04)
  • [3] Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ
    Ameriks, Michael K.
    Venable, Jennifer D.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (08) : 738 - 753
  • [4] The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
    Zhang, Yingshi
    Xu, Xiangbo
    Yang, Kaisi
    Wang, Shuai
    Zhang, Tianqi
    Hui, Fuhai
    Zheng, Fangyuan
    Geng, Hefeng
    Xu, Chang
    Xun, Fanghua
    Xu, Ziang
    Wang, Chengkang
    Hou, Shanbo
    Song, Aigang
    Ren, Tianshu
    Zhao, Qingchun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 983
  • [5] Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis
    Raphael, Jacques
    Desautels, Danielle
    Pritchard, Kathleen I.
    Petkova, Ekaterina
    Shah, Prakeshkumar S.
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 38 - 46
  • [6] Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
    Huang, Xueqin
    You, Li
    Nepovimova, Eugenie
    Psotka, Miroslav
    Malinak, David
    Valko, Marian
    Sivak, Ladislav
    Korabecny, Jan
    Heger, Zbynek
    Adam, Vojtech
    Wu, Qinghua
    Kuca, Kamil
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [7] Phosphoinositide 3-kinase δ (PI3Kδ) in respiratory disease
    Stokes, Clare A.
    Condliffe, Alison M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 361 - 369
  • [8] Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Sabbah, Dima A.
    Hu, Jian
    Zhong, Haizhen A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (13) : 1413 - 1426
  • [9] Significance of phosphoinositide 3-kinase inhibitors in advanced breast cancer: a systematic review and meta-analysis
    Naqi, Asma
    Khan, Mohammad Ahmed
    Najmi, Abul Kalam
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (03): : 950 - 959
  • [10] Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
    Fang X.
    Zhou X.
    Wang X.
    Biomarker Research, 1 (1)
12345